stockrow
Friday 6 November 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
12.82
0.97
−7.03%
Follow CC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.35 | 0.54 | 0.57 | 0.31 | |
P/FCF ratio |
10.07 | 14.23 | 21.57 | 34.73 | |
P/Operating CF |
13.78 | 19.64 | (75.49) | 12.93 | |
P/B ratio |
13.16 | 0.00 | 15.38 | 7.06 | |
Price to Tangible BV |
19.01 | 0.00 | 19.77 | 8.73 | |
EV/Sales |
0.88 | 1.09 | 1.18 | 0.90 | |
EV/EBITDA |
23.72 | 29.05 | 27.47 | 18.26 | |
EV/Operating CF |
12.87 | 15.88 | 20.77 | 19.85 | |
EV/FCF |
25.23 | 28.92 | 44.78 | 102.75 | |
Quick Ratio |
0.93 | 0.85 | 0.82 | 0.80 | |
Current Ratio |
1.81 | 1.66 | 1.82 | 1.78 | |
Net Debt/EBITDA |
0.00 | (24.44) | 33.09 | 54.20 | |
Debt/Assets |
52.56% | 54.15% | 56.93% | 56.10% | |
Debt/Equity |
24.57 | (80.67) | 19.15 | 16.50 | |
Asset Turnover |
0.79 | 0.79 | 0.79 | 0.78 | |
Operating CF/Net income |
0.76 | (0.58) | 1.52 | (2.91) | |
Capex/Depreciation |
(0.61) | (0.54) | (0.60) | (0.63) | |
Interest Coverage |
3.32 | (3.13) | 0.38 | (0.28) | |
Research and Development Expense of Revenue |
1.56% | 1.70% | 1.88% | 2.03% | |
Selling, General and Administrative Expense of Revenue |
(1.62%) | 29.48% | 10.64% | 10.75% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.26% | 0.44% | 0.51% | 0.30% | |
Graham Net Nets |
(1.91) | (1.32) | (1.24) | (2.33) | |
Graham Number |
0.00 | 3.70 | 0.00 | 0.00 | |
Earnings Yield |
(7.50%) | (9.32%) | (11.99%) | (21.06%) | |
Free Cash Flow Yield |
9.93% | 7.03% | 4.64% | 2.88% | |
Revenue per Share |
10.18 | 10.52 | 9.16 | 8.85 | |
Operating CF per Share |
0.98 | 1.04 | (0.29) | 0.91 | |
Capex per Share |
(0.34) | (0.29) | (0.32) | (0.35) | |
Free Cash Flow per Share |
0.65 | 0.75 | (0.62) | 0.57 | |
Cash per Share |
4.88 | 4.44 | 3.73 | 4.47 | |
Shareholders Equity per Share |
1.03 | (0.32) | 1.43 | 1.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.03 | (0.32) | 1.43 | 1.67 | |
Free Cash Flow |
98.00 | 114.00 | (93.00) | 85.00 | |
Working Capital |
1,442.00 | 1,233.00 | 1,319.00 | 1,315.00 | |
Capital Expenditures |
(51.00) | (44.00) | (49.00) | (52.00) | |
Net Current Asset Value |
(3,918.00) | (4,104.00) | (4,123.00) | (4,130.00) | |
EV/EBIT |
223.81 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.04 | |
Price to Operating Income |
89.29 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
934.50 | 933.00 | 808.50 | 724.50 | |
Average Payables |
1,015.00 | 980.00 | 948.50 | 1,055.00 | |
Average Inventory |
1,511.00 | 1,505.00 | 1,543.00 | 1,516.00 | |
Average Assets |
7,431.50 | 7,319.00 | 7,330.50 | 7,445.50 | |
Average Common Equity |
228.00 | 95.50 | 398.00 | 411.50 |
Columns are period end dates · fundamentals updated 5 Nov 2026